Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS4 Cap. Regulatory News (SFOR)

Share Price Information for S4 Cap. (SFOR)

Share Price is delayed by 15 minutes
Get Live Data
41.55    -1.75 (-4.04%)
Bid:
41.30
Ask:
42.00
Spread: 0.70 (1.695%)
Market Cap: £276.67m
SFOR Live PriceLast checked at - London Stock Exchange

Intraday S4 Cap. Share Chart

Director Declaration

27 Mar 2017 12:18

RNS Number : 6302A
Derriston Capital PLC
27 March 2017
 

Derriston Capital plc

 

Director Declaration

 

Derriston Capital plc, which has been created to consider opportunities within the global medical technology industry, announces that Harry Hyman, non-executive Chairman, is a non-executive Director of BioPharma Credit plc, which began trading on the London Stock Exchange this morning.

 

For information please contact:

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

lifesciences@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNMMGZFMNVGNZM
Date   Source Headline
6th Feb 20247:00 amRNSTransaction in Own Shares
5th Feb 20247:00 amRNSTransaction in Own Shares
2nd Feb 20247:00 amRNSTransaction in Own Shares
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20244:24 pmRNSDirector/PDMR Shareholding
26th Jan 20247:00 amRNSShare Buyback Programme
22nd Jan 20241:55 pmRNSReplacement: Fourth Quarter Trading Update
22nd Jan 20247:00 amRNSFourth Quarter Trading Update
16th Jan 20244:21 pmRNSTrading Statement to be released 22nd January
2nd Jan 202412:01 pmRNSTotal Voting Rights
20th Dec 202310:37 amRNSHolding(s) in Company
18th Dec 20233:36 pmRNSHolding(s) in Company
1st Dec 20237:00 amRNSIssue of Shares
9th Nov 20237:00 amRNSThird Quarter Trading Update
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSQ3 Trading Update to be released on 9th November
27th Oct 20237:00 amRNSIssue of Shares
11th Oct 20237:00 amRNSIssue of Shares
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20232:02 pmRNSHolding(s) in Company
18th Sep 202310:00 amRNSHolding(s) in Company
18th Sep 20237:00 amRNSInterim Results for 2023
4th Sep 20237:00 amRNSNotice of Interim Results
1st Sep 20239:00 amRNSIssue of Shares
1st Sep 20237:00 amRNSTotal Voting Rights
3rd Aug 20237:00 amRNSIssue of Shares
24th Jul 20237:00 amRNSTrading Update
14th Jul 202310:00 amRNSDirector/PDMR Shareholding
3rd Jul 20232:00 pmRNSTotal Voting Rights
28th Jun 20237:00 amRNSArtificial Intelligence Briefing
22nd Jun 20237:00 amRNSIssue of Shares
9th Jun 20234:17 pmRNSResult of AGM
9th Jun 20237:00 amRNSAGM Statement
2nd Jun 20237:00 amRNSIssue of Shares
16th May 20239:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSFirst Quarter Trading Update
9th May 20237:00 amRNSNotice of Q1 Results
28th Apr 20237:00 amRNSAnnual Financial Report and Notice of AGM
17th Apr 20237:00 amRNSUpdate regarding Executive Chair
29th Mar 20234:51 pmRNSUnaudited 2022 preliminary results
15th Mar 20234:22 pmRNSNotice of Results
3rd Mar 202311:00 amRNSHolding(s) in Company
6th Feb 20234:05 pmRNSUpdate regarding Executive Chair
1st Feb 202310:00 amRNSTotal Voting Rights
18th Jan 20237:00 amRNSFourth Quarter Trading update
4th Jan 20237:00 amRNSIssue of Shares
3rd Jan 202310:24 amRNSTotal Voting Rights
13th Dec 20227:00 amRNSIssue of Shares
6th Dec 20229:00 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.